**Core Concept**
Proliferation-independent agents are a class of drugs that do not require cell division to exert their effects. These agents interfere with cellular processes that are not specific to cell proliferation, such as DNA repair, angiogenesis, or apoptosis.

**Why the Correct Answer is Right**
Proliferation-independent agents target various cellular pathways that are not directly related to cell cycle progression. For example, angiogenesis inhibitors, such as bevacizumab, target vascular endothelial growth factor (VEGF) and prevent the formation of new blood vessels, which is essential for tumor growth. Similarly, DNA repair inhibitors, such as olaparib, target enzymes involved in DNA repair mechanisms, leading to the accumulation of DNA damage and subsequent cell death. These agents can induce cell death in both proliferating and non-proliferating cells.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because [insert reason, e.g. it's a proliferation-dependent agent].
**Option B:** This option is incorrect because [insert reason, e.g. it's not a proliferation-independent agent].
**Option C:** This option is incorrect because [insert reason, e.g. it's a proliferation-dependent agent].

**Clinical Pearl / High-Yield Fact**
One key point to remember is that proliferation-independent agents can induce cell death in both proliferating and non-proliferating cells, making them an attractive option for treating cancers with limited treatment options.

**Correct Answer: B. This option is incorrect because it's a proliferation-dependent agent.**